Home / Stocks / LH

Labcorp Holdings (LH, Health Care Services) Stock Valuation & Fair Value Trading above fair value

Labcorp Holdings (LH, Health Care Services) trades at a blended P/E of 18.1, about 22% above its historical normal valuation, with a forward growth estimate of 8.8% and a PEG of 2.05. Analysts' one-year estimates have been hit 64% of the time.

DATA AS OF 2026-08-21
Blended P/E
18.1
Normal P/E
14.8
PEG
2.05
Fwd growth
8.8%
Div yield
0.9%
RSI (14)
75.8
Overbought

The Street vs SeerForecast

Wall Street's mean price target for LH is $337.75 across 16 analysts, 0.4% above the current price. The average analyst rating is Buy. Our SeerForecast read of the same stock, formed without analyst targets: trading above fair value. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer's rating moved from fairly valued (2026-06-03) to trading above fair value (2026-08-21).

Price and rating by weekClose moved +22.9 percent from 2026-06-03 to 2026-08-17, with 3 rating changes over 21 recorded weeks.2026-06-03: Fairly valued, close 258.92 (recalculated)2026-06-10: Fairly valued, close 268.63 (recalculated)2026-06-14: Fairly valued, close 266.16 (recalculated)2026-06-16: Fairly valued, close 264.76 (recalculated)2026-06-21: Fairly valued, close 255.82 (recalculated)2026-07-02: Fairly valued, close 286.98 (recalculated)2026-07-06: Fairly valued, close 284.39 (recalculated)2026-07-09: Fairly valued, close 277.63 (recalculated)2026-07-12: Fairly valued, close 276.81 (recalculated)2026-07-13: Fairly valued, close 276.68 (recalculated)2026-07-14: Fairly valued, close 275.68 (recalculated)2026-07-20: Fairly valued, close 281.48 (recalculated)2026-07-22: Fairly valued, close 281.46 (recalculated)2026-07-25: Fairly valued, close 296.77 (recalculated)2026-07-27: Fairly valued, close 301.17 (recalculated)2026-07-31: Trading above fair value, close 309.20 (recalculated)2026-08-03: Fairly valued, close 309.202026-08-07: Trading above fair value, close 319.17 (recalculated)2026-08-10: Trading above fair value, close 319.172026-08-14: Trading above fair value, close 318.13 (recalculated)2026-08-17: Trading above fair value, close 318.132593182026-06-032026-08-17
Attractively valuedFairly valuedAbove fair valueLarger dot: a stronger reading

Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.

2026-06-03P/E 15.4+4%Fairly valued
2026-06-10P/E 15.5+5%Fairly valued
2026-06-14P/E 15.5+5%Fairly valued
2026-06-16P/E 15.5+5%Fairly valued
2026-06-21P/E 15.5+5%Fairly valued
2026-07-02P/E 16.5+12%Fairly valued
2026-07-06P/E 16.7+13%Fairly valued
2026-07-09P/E 16.7+13%Fairly valued
2026-07-12P/E 16.0+9%Fairly valued
2026-07-13P/E 16.0+9%Fairly valued
2026-07-14P/E 16.0+9%Fairly valued
2026-07-20P/E 16.4+11%Fairly valued
2026-07-22P/E 16.4+11%Fairly valued
2026-07-25P/E 17.1+16%Fairly valued
2026-07-27P/E 17.1+16%Fairly valued
2026-07-31P/E 18.0+22%Trading above fair value
2026-08-03P/E 17.6+19%Fairly valued
2026-08-07P/E 18.0+22%Trading above fair value
2026-08-10P/E 18.2+23%Trading above fair value
2026-08-14P/E 18.3+24%Trading above fair value
2026-08-17P/E 18.1+22%Trading above fair value
2026-08-21P/E 18.1+22%Trading above fair value ← now

Frequently asked questions

Is Labcorp Holdings stock overvalued?

At a blended P/E of 18.1 versus its historical normal P/E of 14.8, Labcorp Holdings trades about 22% above its typical valuation, with a PEG of 2.05 on 8.8% forward growth. tickerseer currently rates it trading above fair value.

What is Labcorp Holdings's fair value and PEG?

Labcorp Holdings trades at a blended P/E of 18.1 against a historical normal P/E of 14.8, a PEG of 2.05, and a forward growth estimate of 8.8%.

Has tickerseer's rating of Labcorp Holdings changed?

tickerseer's rating moved from fairly valued (2026-06-03) to trading above fair value (2026-08-21).

What is the analyst price target for Labcorp Holdings?

The mean Wall Street price target for Labcorp Holdings is $337.75 across 16 analysts, 0.4% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Health Care Services. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track LH free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. Educational content, not investment advice.